Preferred Label : Prognostic Stage II Breast Cancer AJCC v8;
NCIt synonyms : Prognostic Stage II Breast Carcinoma AJCC v8;
NCIt related terms : Stage II Breast Cancer;
NCIt definition : Stage II includes: IIA: (T1, N0, M0, G1, HER2 Status: Negative, ER Status: Negative,
PR Status: Negative); (T1, N0, M0, G2, HER2 Status: Negative, ER Status: Negative,
PR Status: Negative); (T1, N0, M0, G3, HER2 Status: Negative, ER Status: Positive,
PR Status: Negative); (T1, N0, M0, G3, HER2 Status: Negative, ER Status: Negative,
PR Status: Positive); (T1, N0, M0, G3, HER2 Status: Negative, ER Status: Negative,
PR Status: Negative); (T0-1, N1mi, M0, G1, HER2 Status: Negative, ER Status: Negative,
PR Status: Negative); (T0-1, N1mi, M0, G2, HER2 Status: Negative, ER Status: Negative,
PR Status: Negative); (T0-1, N1mi, M0, G3, HER2 Status: Negative, ER Status: Positive,
PR Status: Negative); (T0-1, N1mi, M0, G3, HER2 Status: Negative, ER Status: Negative,
PR Status: Positive); (T0-1, N1mi, M0, G3, HER2 Status: Negative, ER Status: Negative,
PR Status: Negative); (T0-1, N1, M0, G1, HER2 Status: Positive, ER Status: Positive,
PR Status: Negative); (T0-1, N1, M0, G1-2, HER2 Status: Positive, ER Status: Negative,
PR Status: Any); (T0-1, N1, M0, G1, HER2 Status: Negative, ER Status: Positive, PR
Status: Negative); (T0-1, N1, M0, G1, HER2 Status: Negative, ER Status: Negative,
PR Status: Positive); (T0-1, N1, M0, G3, HER2 Status: Negative, ER Status: Positive,
PR Status: Positive); (T2, N0, M0, G1, HER2 Status: Positive, ER Status: Positive,
PR Status: Negative); (T2, N0, M0, G1-2, HER2 Status: Positive, ER Status: Negative,
PR Status: Any); (T2, N0, M0, G1, HER2 Status: Negative, ER Status: Positive, PR Status:
Negative); (T2, N0, M0, G1, HER2 Status: Negative, ER Status: Negative, PR Status:
Positive); (T2, N0, M0, G3, HER2 Status: Negative, ER Status: Positive, PR Status:
Positive); (T0-2, N2, M0, G1, HER2 Status: Negative, ER Status: Positive, PR Status:
Positive); (T3, N1-2, M0, G1, HER2 Status: Negative, ER Status: Positive, PR Status:
Positive); IIB: (T0-1, N1, M0, G1, HER2 Status: Negative, ER Status: Negative, PR
Status: Negative); (T0-1, N1, M0, G2, HER2 Status: Positive, ER Status: Positive,
PR Status: Negative); (T0-1, N1, M0, G2, HER2 Status: Negative, ER Status: Positive,
PR Status: Negative); (T0-1, N1, M0, G2, HER2 Status: Negative, ER Status: Negative,
PR Status: Positive); (T0-1, N1, M0, G3, HER2 Status: Positive, ER Status: Positive,
PR Status: Negative); (T0-1, N1, M0, G3, HER2 Status: Positive, ER Status: Negative,
PR Status: Any); (T2, N0, M0, G1, HER2 Status: Negative, ER Status: Negative, PR Status:
Negative); (T2, N0, M0, G2, HER2 Status: Positive, ER Status: Positive, PR Status:
Negative); (T2, N0, M0, G2, HER2 Status: Negative, ER Status: Positive, PR Status:
Negative); (T2, N0, M0, G2, HER2 Status: Negative, ER Status: Negative, PR Status:
Positive); (T2, N0, M0, G3, HER2 Status: Positive, ER Status: Positive, PR Status:
Negative); (T2, N0, M0, G3, HER2 Status: Positive, ER Status: Negative, PR Status:
Any); (T2, N1, M0, G1, HER2 Status: Positive, ER Status: Any, PR Status: Any); (T2,
N1, M0, G1, HER2 Status: Negative, ER Status: Negative, PR Status: Positive); (T0-2,
N2, M0, G2, HER2 Status: Negative, ER Status: Positive, PR Status: Positive); (T0-2,
N2, M0, G3, HER2 Status: Positive, ER Status: Positive, PR Status: Positive); (T3,
N1-2, M0, G2, HER2 Status: Negative, ER Status: Positive, PR Status: Positive); (T3,
N1-2, M0, G3, HER2 Status: Positive, ER Status: Positive, PR Status: Positive). T0:
No evidence of primary tumor. T1: Tumor measuring 20 mm or less in greatest dimension.
T2: Tumor measuring more than 20 mm, but not more than 50 mm in greatest dimension.
T3: Tumor measuring more than 50 mm in greatest dimension. N0: No regional lymph node
metastasis is identified or isolated tumor cell clusters (ITCs) are identified only.
N1: Tumor with micrometastases; or metastases in 1-3 axillary lymph nodes; and/or
clinically negative internal mammary nodes with micrometastases or macrometastases
by sentinel lymph node biopsy. N1mi: Micrometastases (approximately 200 cells,...;
Neoplastic status : Malignant;
NCI Metathesaurus CUI : CL526894;
Origin ID : C139569;
UMLS CUI : C4528580;
Automatic exact mappings (from CISMeF team)
- Disease excludes abnormal cell
- Has associated anatomic sites
- Semantic type(s)
- concept_is_in_subset
- disease_excludes_finding
- disease_has_abnormal_cell
- disease_has_finding
- disease_has_normal_cell_origin
- disease_has_normal_tissue_origin
- disease_has_primary_anatomic_site
- disease_is_stage
